Old Web
English
Sign In
Acemap
>
authorDetail
>
H. van de Velde
H. van de Velde
Takeda Pharmaceutical Company
Pathology
Multiple myeloma
Medicine
Oncology
Treatment Arm
2
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The current unmet medical needs in the treatment and management of multiple myeloma (MM)
2015
Clinical Lymphoma, Myeloma & Leukemia
Paul G. Richardson
A. Palumbo
M.V. Mateos
H. van de Velde
Tomas Skacel
Sagar Lonial
Show All
Source
Cite
Save
Citations (1)
Matched-pairs analysis of outcomes with bortezomib, melphalan, and prednisone (VMP) treatment for previously untreated multiple myeloma (MM) using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials
2015
Clinical Lymphoma, Myeloma & Leukemia
M-V. Mateos
Albert Oriol
Joaquin Martinez-Lopez
Ana-Isabel Teruel
Enrique Bengoechea
Luis Palomera
F de Arriba
Dixie-Lee Esseltine
Andrew Cakana
Lixia Pei
H. van de Velde
J. F. San Miguel
Show All
Source
Cite
Save
Citations (2)
1